Skip to main content
Clinical Trials/IRCT20160307026950N6
IRCT20160307026950N6
Completed
Phase 3

Comparison of the Effects of Low-Dose Midazolam and Low-Dose etomidate on Prevention of Etomidate-Induced Myoclonus in electroconvulsive therapy

Esfahan University of Medical Sciences0 sites120 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Myoclonic Movements.
Sponsor
Esfahan University of Medical Sciences
Enrollment
120
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • All Patients candidate Electroconvulsive Therapy
  • ASA I,ASAII
  • Age 6 \- 15 years

Exclusion Criteria

  • Severe cardiovascular disease
  • kidney disease
  • Liver disease
  • Chronic respiratory disease
  • drugs Allergy
  • discontinue of cooperation

Outcomes

Primary Outcomes

Not specified

Similar Trials